Identification of interstitial lung diseases using deep learning

The advanced medical imaging provides various advantages to both the patients and the healthcare providers. Medical Imaging truly helps the doctor to determine the inconveniences in a human body and empowers them to make better choices. Deep learning has an important role in the medical field especially for medical image analysis today. It is an advanced technique in the machine learning concept which can be used to get efficient output than using any other previous techniques. In the anticipated work deep learning is used to find the presence of interstitial lung diseases (ILD) by analyzing high-resolution computed tomography (HRCT) images and identifying the ILD category. The efficiency of the diagnosis of ILD through clinical history is less than 20%. Currently, an open chest biopsy is the best way of confirming the presence of ILD. HRCT images can be used effectively to avoid open chest biopsy and improve accuracy. In this proposed work multi-label classification is done for 17 different categories of ILD. The average accuracy of 95% is obtained by extracting features with the help of a convolutional neural network (CNN) architecture called SmallerVGGNet

Trends in Computer-Aided Diagnosis Using Deep 2 Learning Techniques: A Review of Recent Studies on 3 Algorithm Development 4

With recent focus on deep neural network architectures for development of algorithms for computer-aided diagnosis (CAD), we provide a review of studies within the last 3 years (2015-2017) reported in selected top journals and conferences. 29 studies that met our inclusion criteria were reviewed to identify trends in this field and to inform future development. Studies have focused mostly on cancer-related diseases within internal medicine while diseases within gender-/age-focused fields like gynaecology/pediatrics have not received much focus. All reviewed studies employed image datasets, mostly sourced from publicly available databases (55.2%) and few based on data from human subjects (31%) and non-medical datasets (13.8%), while CNN architecture was employed in most (70%) of the studies. Confirmation of the effect of data manipulation on quality of output and adoption of multi-class rather than binary classification also require more focus. Future studies should leverage collaborations with medical experts to aid future with actual clinical testing with reporting based on some generally applicable index to enable comparison. Our next steps on plans for CAD development for osteoarthritis (OA), with plans to consider multi-class classification and comparison across deep learning approaches and unsupervised architectures were also highlighted

A survey of deep learning models in medical therapeutic areas.

pre-print1407 K

Innovations in thoracic imaging:CT, radiomics, AI and x-ray velocimetry

In recent years, pulmonary imaging has seen enormous progress, with the introduction, validation and implementation of new hardware and software. There is a general trend from mere visual evaluation of radiological images to quantification of abnormalities and biomarkers, and assessment of 'non visual' markers that contribute to establishing diagnosis or prognosis. Important catalysts to these developments in thoracic imaging include new indications (like computed tomography [CT] lung cancer screening) and the COVID-19 pandemic. This review focuses on developments in CT, radiomics, artificial intelligence (AI) and x-ray velocimetry for imaging of the lungs. Recent developments in CT include the potential for ultra-low-dose CT imaging for lung nodules, and the advent of a new generation of CT systems based on photon-counting detector technology. Radiomics has demonstrated potential towards predictive and prognostic tasks particularly in lung cancer, previously not achievable by visual inspection by radiologists, exploiting high dimensional patterns (mostly texture related) on medical imaging data. Deep learning technology has revolutionized the field of AI and as a result, performance of AI algorithms is approaching human performance for an increasing number of specific tasks. X-ray velocimetry integrates x-ray (fluoroscopic) imaging with unique image processing to produce quantitative four dimensional measurement of lung tissue motion, and accurate calculations of lung ventilation

Unsupervised and Weakly-Supervised Learning of Localized Texture Patterns of Lung Diseases on Computed Tomography

Computed tomography (CT) imaging enables in vivo assessment of lung parenchyma and several lung diseases. CT scans are key in particular for the diagnosis of 1) chronic obstructive pulmonary disease (COPD), which is the fourth leading cause of death worldwide, and largely overlaps with pulmonary emphysema; and 2) lung cancer, which is the first leading cause of cancer-related death, and manifests in its early stage with the presence of lung nodules. Most lung CT image analysis methods to-date have relied on supervised learning requiring manually annotated local regions of interest (ROIs), which are slow and labor-intensive to obtain. Machine learning models requiring less or no manual annotations are important for a sustainable development of computer-aided diagnosis (CAD) systems. This thesis focused on exploiting CT scans for lung disease characterization via two learning strategies: 1) fully unsupervised learning on a very large amount of unannotated image patches to discover novel lung texture patterns for pulmonary emphysema; and 2) weakly-supervised learning to generate voxel-level localization of lung nodules from CT whole-slice labels. In the first part of this thesis, we proposed an original unsupervised approach to learn emphysema-specific radiological texture patterns. We have designed dedicated spatial and texture features and a two-stage learning strategy incorporating clustering and graph partitioning. Learning was performed on a cohort of 2,922 high-resolution full-lung CT scans, which included a high prevalence of smokers and COPD subjects. Experiments lead to discovering 10 highly-reproducible spatially-informed lung texture patterns and 6 quantitative emphysema subtypes (QES). Our discovered QES were associated independently with distinct risk of symptoms, physiological changes, exacerbations and mortality. Genome-wide association studies identified loci associated with four subtypes. Then we designed a deep-learning approach, using unsupervised domain adaptation with adversarial training, to label the QES on cardiac CT scans, which included approximately 70% of the lung. Our proposed method accounted for the differences in CT image qualities, and enabled us to study the progression of QES on a cohort of 17,039 longitudinal cardiac and full-lung CT scans. Overall, the discovered QES provide novel emphysema sub-phenotyping that may facilitate future study of emphysema development, understanding the stages of COPD and the design of personalized therapies. In the second part of the thesis, we have designed a deep-learning method for lung nodule detection with weak labels, using classification convolutional neural networks (CNNs) with skip-connections to generate high-quality discriminative class activation maps, and a novel candidate screening framework to reduce the number of false positives. Given that the vast majority of annotated nodules are benign, we further exploited a data augmentation framework with a generative adversarial network (GAN) to address the issue of data imbalance for lung cancer prediction. Our weakly-supervised lung nodule detection on 1,000s CT scans achieved competitive performance compared to a fully-supervised method, while requiring 100 times less annotations. Our data augmentation framework enabled synthesizing nodules with high fidelity in specified categories, and is beneficial for predicting nodule malignancy scores and hence improving the accuracy / reliability of lung cancer screening